http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2431470-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7cfdee848ec14a0c7b11217e50282956 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-721 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-717 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
| filingDate | 2010-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13e4592c518ef3dfba08c9728940e460 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6acd0940ff7942386ae01270e3154012 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48f046bc995e968d3a1e683c849e7bd4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61309f93046f3329a0094df4a61e4a4b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64ed4ec2d937953eaa12489134bd856d |
| publicationDate | 2011-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2431470-C1 |
| titleOfInvention | Eye drops |
| abstract | FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention refers to pharmaceutical industry and medicine, and concerns a lachrymal substitute preparation which can be used for local therapy in an ocular surface disease. The invention has a composition (g/l): hydroxypropyl methylcellulose 2.5-5.0; disodium phosphate 5.5-16.5; sodium dihydrogen phosphate 0.8-1.5; sodium chloride 2.0-8.0; disodium edetate 0.1-0.5; benzalkonium chloride 0.03-0.09; dextrane 0.5-1.5; water for injections up to 1 l. The composition has the balanced proportions providing the pH value within 6.5 to 7.8, contains a polymeric composition containing hydroxypropyl methylcellulose and dextrane. As dextrane, either dextrane 40, or dextrane 60, or dextrane 70 is used. ^ EFFECT: invention provides ocular surface moistening that allows relieving or eliminating irritation symptoms caused by the ocular surface disease. ^ 1 tbl, 2 ex |
| priorityDate | 2010-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.